======= DPH3 ======= == Gene Information == * **Official Symbol**: DPH3 * **Official Name**: diphthamide biosynthesis 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=285381|285381]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96FX2|Q96FX2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DPH3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPH3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608959|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Essential for the first step in the synthesis of diphthamide, a post-translational modification of histidine which occurs in elongation factor 2 (EEF2) and which can be ADP- ribosylated by diphtheria toxin and by Pseudomonas exotoxin A (Eta). {ECO:0000250}. |zf-CSL| |peptidyl-diphthamide biosynthetic process from peptidyl-histidine| |peptidyl-diphthamide metabolic process| |peptidyl-histidine modification| |regulation of cytoplasmic translational elongation| |tRNA wobble uridine modification| |regulation of translational elongation| |tRNA wobble base modification| |regulation of cytoplasmic translation| |tRNA modification| |tRNA processing| |negative regulation of protein secretion| |negative regulation of peptide secretion| |RNA modification| |positive regulation of binding| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |tRNA metabolic process| |negative regulation of secretion by cell| |negative regulation of secretion| |regulation of translation| |regulation of binding| |ncRNA processing| |regulation of cellular amide metabolic process| |regulation of protein secretion| |ncRNA metabolic process| |negative regulation of transport| |regulation of peptide secretion| |posttranscriptional regulation of gene expression| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |RNA processing| |peptidyl-amino acid modification| |regulation of protein localization| |RNA metabolic process| |positive regulation of molecular function| |regulation of transport| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-2.25| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.86| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-1.8| |[[:results:exp131|L-74142 5μM R03 exp131]]|-1.73| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|1.71| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.71| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|1.72| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|1.76| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|1.76| |[[:results:exp67|BVD-523 15μM R02 exp67]]|1.85| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.93| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.94| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|1.98| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.99| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|2.15| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|2.31| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|2.36| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.49| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.52| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.68| |[[:results:exp359|FK-506 30μM R07 exp359]]|2.71| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.16| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|3.17| |[[:results:exp135|MS023 7μM R03 exp135]]|3.73| |[[:results:exp134|MS023 2μM R03 exp134]]|3.77| |[[:results:exp85|UM0129480 7μM R02 exp85]]|4.57| ^Gene^Correlation^ |[[:human genes:c:ctu1|CTU1]]|0.686| |[[:human genes:e:elp3|ELP3]]|0.67| |[[:human genes:e:elp6|ELP6]]|0.653| |[[:human genes:e:elp2|ELP2]]|0.65| |[[:human genes:m:mocs3|MOCS3]]|0.641| |[[:human genes:u:urm1|URM1]]|0.635| |[[:human genes:k:kti12|KTI12]]|0.629| |[[:human genes:c:ctu2|CTU2]]|0.623| |[[:human genes:d:dph1|DPH1]]|0.615| |[[:human genes:i:ikbkap|IKBKAP]]|0.582| |[[:human genes:d:dph5|DPH5]]|0.535| |[[:human genes:e:elp5|ELP5]]|0.529| |[[:human genes:e:elp4|ELP4]]|0.507| |[[:human genes:n:nr2c2ap|NR2C2AP]]|0.507| |[[:human genes:d:dnajc24|DNAJC24]]|0.498| |[[:human genes:d:dph2|DPH2]]|0.483| |[[:human genes:c:c7orf26|C7orf26]]|0.453| |[[:human genes:s:sbds|SBDS]]|0.418| |[[:human genes:t:thg1l|THG1L]]|0.409| |[[:human genes:a:alkbh8|ALKBH8]]|0.401| |[[:human genes:r:rbm26|RBM26]]|0.4| Global Fraction of Cell Lines Where Essential: 576/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|19/28| |blood|15/28| |bone|22/26| |breast|23/33| |central nervous system|49/56| |cervix|3/4| |colorectal|13/17| |esophagus|10/13| |fibroblast|1/1| |gastric|12/16| |kidney|21/21| |liver|16/20| |lung|52/75| |lymphocyte|11/16| |ovary|19/26| |pancreas|21/24| |peripheral nervous system|14/16| |plasma cell|6/15| |prostate|1/1| |skin|23/24| |soft tissue|8/9| |thyroid|1/2| |upper aerodigestive|19/22| |urinary tract|26/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1514 * **Expression level (log2 read counts)**: 4.34 {{:chemogenomics:nalm6 dist.png?nolink |}}